Trump plans 200% tariff on imported drugs, raising risk of higher US prices and shortages

US President Donald Trump has threatened pharmaceutical import tariffs of up to 200 per cent, a move that experts warn could raise drug costs and create shortages across the United States. Analysts say stockpiling may delay pain until 2027, but generics and low-income patients would suffer most. Indias exporters have been excluded from immediate enforcement. Courts have questioned the administrations authority and the issue may reach the Supreme Court. The policy forces a choice between reshoring production and preserving affordable access.